Phibro Animal Health Corporation - (PAHC): Price and Financial Metrics
Phibro Animal Health Corporation - (PAHC)
Today's Latest Price: $21.25 USD
Updated Jan 22 4:00pm
Add PAHC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
PAHC Stock Summary
- Phibro Animal Health Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 89.43% of US listed stocks.
- PAHC's went public 6.79 years ago, making it older than just 24.86% of listed US stocks we're tracking.
- Of note is the ratio of Phibro Animal Health Corp's sales and general administrative expense to its total operating expenses; 88.08% of US stocks have a lower such ratio.
- Stocks that are quantitatively similar to PAHC, based on their financial statements, market capitalization, and price volatility, are PRIM, ARC, KRO, CRI, and SGMA.
- Visit PAHC's SEC page to see the company's official filings. To visit the company's web site, go to www.pahc.com.
PAHC Stock Price Chart Interactive Chart >
PAHC Price/Volume Stats
| Current price | $21.25 | 52-week high | $29.38 |
| Prev. close | $21.32 | 52-week low | $16.27 |
| Day low | $21.01 | Volume | 89,800 |
| Day high | $21.40 | Avg. volume | 121,793 |
| 50-day MA | $19.47 | Dividend yield | 2.26% |
| 200-day MA | $21.40 | Market Cap | 859.63M |
Phibro Animal Health Corporation - (PAHC) Company Bio
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company was founded in 2000 and is based in Teaneck, New Jersey.
PAHC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $21.25 | $17.33 | -19% |
We started the process of determining a valid price forecast for Phibro Animal Health Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Phibro Animal Health Corp ranked in the 46th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 18.33%. In terms of the factors that were most noteworthy in this DCF analysis for PAHC, they are:
- The company's balance sheet shows it gets 68% of its capital from equity, and 32% of its capital from debt. Notably, its equity weight is greater than only 18.59% of US equities in the Healthcare sector yielding a positive free cash flow.
- Phibro Animal Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 7.31% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -20% |
| 1% | -20% |
| 2% | -19% |
| 3% | -18% |
| 4% | -17% |
| 5% | -16% |
Want more companies with a valuation profile/forecast similar to that of Phibro Animal Health Corp? See INBP, IQV, LMAT, BDX, and LCI.
Loading social stream, please wait...